Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

15 Results Found

Letter/Comment
Public

AHA Response to OMB Deregulation RFI

AHA responds to the Office of Management and Budget Deregulation Request for Information.

Litigation: AHA, Hospitals Sue to Require HHS to Meet Deadlines for Deciding Appeals

Appeals court sends order to eliminate backlog of Medicare appeals back to trial court (August 11, 2017)
News

Executive order promotes domestic production of medicines, other executive actions

The Trump administration May 5 issued two executive orders on pharmaceutical manufacturing and life-sciences research.
News

CMS to update SPA template for medication-assisted treatment benefit

The Centers for Medicare & Medicaid Services today released a
Advisory
Member

Trump Administration Issues Additional Deregulation Orders and Notices

The Trump administration April 9 released a series of executive orders (EOs) and took other administrative actions aimed at reducing regulatory burden.
Landing Page
Public

Regulatory Relief

Every day, hospitals, health systems and post-acute care providers confront the daunting task of complying with a growing number of federal regulations.
Advocacy
Public

Affordability Advocacy Agenda

Our shared focus with Congress and Administration is on providing relief from the pandemic, ensuring a smooth recovery, and rebuilding a better health care system for the future. The American Hospital Association continues to incorporate principles that promote improved affordability, value, and equity into our policy and advocacy activities.
Testimony
Public

AHA Statement to Senate Budget Committee on Alleviating Administrative Burden in Health Care

The AHA provides comments before the Senate Committee on Budget on ways to reduce administrative burden and costs in the health care system.
Letter/Comment
Member

AHA Letter to UnitedHealthcare RE: Molecular Pathology Reimbursement Policy

AHA addresses UnitedHealthcare’s implementation of its Molecular Pathology Reimbursement Policy on April 1, 2024.